| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 06/24/2003 | US6583290 14-methyl epothilone derivatives |
| 06/24/2003 | US6583141 T cell mediated rheumatic diseases |
| 06/24/2003 | US6583089 Pre- and postemergence herbicides such as (5,5-dimethyl-1,3-dioxocyclohex-2yl)(6-methoxy-3a,4-dihydro-3H -chromeno(4,3c) isoxazolin-9-yl)methanone, formed by acylation and rearranging in the presence of catalysts |
| 06/19/2003 | WO2003050132A1 6-o-acyl ketolide derivatives of erythromycine useful as antibacterials |
| 06/19/2003 | WO2003050123A1 Fused bicyclic pyridine derivatives as tachykinin receptor antagonists |
| 06/19/2003 | WO2003050064A2 Mitotic kinesin inhibitors |
| 06/19/2003 | WO2003049741A1 Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 06/19/2003 | WO2003049679A2 Mitotic kinesin inhibitors |
| 06/19/2003 | US20030114671 Corticotropin releasing factor antagonists |
| 06/19/2003 | US20030114669 Photochromic spiro(indoline)naphthoxazines |
| 06/19/2003 | US20030114508 Fused imidazolium derivatives |
| 06/19/2003 | US20030114451 Isoxazolo [4,5-d] pyrimidines as CRF antagonists |
| 06/19/2003 | US20030113755 Fluorescent nucleotides and labeling methods using the same |
| 06/19/2003 | US20030113359 Prosthetic device placed on the outside surface of the vessel or graft which then elutes antiproliferatives from a matrix |
| 06/19/2003 | CA2469596A1 Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 06/19/2003 | CA2469304A1 6-o acyl ketolide antibacterials |
| 06/19/2003 | CA2468156A1 Azolopyrimidinone compounds and their use |
| 06/19/2003 | CA2467722A1 Thienopyrimidinone derivatives as mitotic kinesin inhibitors |
| 06/18/2003 | EP1319008A2 Water soluble rapamycin esters |
| 06/18/2003 | EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors |
| 06/18/2003 | EP1318814A2 Triazole compounds useful as protein kinase inhibitors |
| 06/18/2003 | EP1158995B1 Biologically active compounds of ganoderma pfeifferi dms 13239 |
| 06/18/2003 | CN1425017A Synthetic process for intermediate for ecteinascidin and phthalascidin compounds |
| 06/18/2003 | CN1425008A 3-aminoquinazolin-2, 4-dione antibacterial agents |
| 06/17/2003 | US6579869 Cephalotaxanes: their method of preparation and their use in treatment of cancers, leukemias, parasites, including those resistant to usual chemotherapeutic agents, and as reversal agents |
| 06/17/2003 | CA2040606C Chiral catalysts for reduction of ketones and process for their preparation |
| 06/12/2003 | WO2003048137A1 Metabotropic glutamate receptor-5 modulators |
| 06/12/2003 | WO2003048122A2 Inhibitors of cytosolic phospholipase a2 |
| 06/12/2003 | US20030109562 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1, 6,9-trioxa-3-aza-cyclopenta[a]naphthalene |
| 06/12/2003 | US20030109535 GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure:prodrugs, stereoisomers and drugs |
| 06/12/2003 | US20030109516 Tetrahydroquinazoline-2,4-diones and therapeutic uses thereof |
| 06/12/2003 | CA2468067A1 Metabotropic glutamate receptor-5 modulators |
| 06/11/2003 | EP1317460A1 Compounds containing oxazolidinone moiety and uses thereof |
| 06/11/2003 | EP1317452A1 Pyrazole compounds useful as protein kinase inhibitors |
| 06/11/2003 | EP1317450A1 Pyrazole compounds useful as protein kinase inhibitors |
| 06/11/2003 | EP1317449A1 Pyrazole compounds useful as protein kinase inhibitors |
| 06/11/2003 | EP1317448A1 Pyrazole compounds useful as protein kinase inhibitors |
| 06/11/2003 | EP1317447A1 Pyrazole compounds useful as protein kinase inhibitors |
| 06/11/2003 | EP1317444A1 Pyrazole compounds useful as protein kinase inhibitors |
| 06/11/2003 | EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 06/10/2003 | US6576259 Sustained release formulations containing tacrolimus |
| 06/10/2003 | US6576135 Method for separating lactone-containing high-molecular weight compounds |
| 06/10/2003 | CA2067541C Reduction products of rapamycin |
| 06/05/2003 | WO2003045956A1 Process for the preparation of 2-or-9-oxa-3, 7-diazabicyclo (3.3.1) nonanes from 2-aminomethyl-2, 3-dihydrooxazines, intermediates therefore, and processes for preparing such intermediates |
| 06/05/2003 | WO2003045919A2 Process for the synthesis of amine ethers from secondary amino oxides and uses |
| 06/05/2003 | WO2003045329A2 Methods for the purification of levofloxacin |
| 06/05/2003 | WO2003045319A2 Targeted therapeutics and uses thereof |
| 06/05/2003 | WO2003045315A2 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses |
| 06/05/2003 | WO2003045312A2 Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin |
| 06/05/2003 | WO2002085843A3 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 06/05/2003 | WO2002028863A8 New oxabispidine compound useful in the treatment of cardiac arrhythmias |
| 06/05/2003 | US20030105375 An ion-containing compound is admixed with macromolecular crown ether or derivatives to form an extractant/ion complex, and the predetermined extractant/ion complex is separated from the diluent by using the new phase affinity |
| 06/05/2003 | US20030105102 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting PARP activity |
| 06/05/2003 | US20030105099 Novel compounds and compositions as cathepsin inhibitors |
| 06/05/2003 | US20030105090 For therapy of cancer, diabetes |
| 06/05/2003 | US20030105087 New polycyclic azaindole compounds |
| 06/05/2003 | US20030105086 Antimicrobial agents and uses thereof |
| 06/05/2003 | US20030105081 Heterocyclic compounds as ligands of the GABAA receptor |
| 06/05/2003 | US20030105074 Phthalazine compounds and therapeutic agents for erectile dysfunction |
| 06/05/2003 | US20030104974 Dual inhibitorsof PDE 7 and PDE 4 |
| 06/05/2003 | US20030104585 Gene clusters for formation of pipecolic acid for inclusion into rapamycins; polyketide synthases; immunosuppressants |
| 06/05/2003 | US20030104515 "Process for preparing cephalosporanic acid derivatives using alpha-ketoacid derivatives" |
| 06/05/2003 | CA2466860A1 Methods for the purification of levofloxacin |
| 06/05/2003 | CA2465846A1 Targeted therapeutics and uses thereof |
| 06/05/2003 | CA2465840A1 Process for the preparation of 2-or-9-oxa-3, 7-diazabicyclo (3.3.1) nonanes from 2-aminomethyl-2, 3-dihydrooxazines, intermediates therefore, and processes for preparing such intermediates |
| 06/05/2003 | CA2464107A1 Process for the synthesis of amine ethers from secondary amino oxides and uses |
| 06/05/2003 | CA2463592A1 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses |
| 06/04/2003 | EP1315739A2 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof |
| 06/04/2003 | EP1315733A2 Method for producing anellated tetrahydro-[1h]-triazoles |
| 06/04/2003 | EP1315720A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 06/04/2003 | EP1315718A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 06/04/2003 | EP1315716A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 06/04/2003 | EP1315706A1 Heterocyclically substituted benzoylcyclohexanediones, methods for producing them and their use as herbicides |
| 06/04/2003 | EP1252150B1 Heterocyclic derivatives, preparation method and pharmaceutical compositions containing same |
| 06/04/2003 | EP1062217B1 Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives |
| 06/04/2003 | EP0783507B1 Compounds useful as antiproliferative agents and garft inhibitors |
| 06/04/2003 | EP0759437B1 Processes for the production of 2-isocephem derivatives |
| 06/04/2003 | CN1422256A Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredent |
| 06/04/2003 | CN1110497C Di-or triaza-spiral [4,5] decane derivative |
| 06/03/2003 | US6573377 Antitumor agent capable of showing its efficacy even against 5- FU drug resistant tumors |
| 06/03/2003 | US6573260 Cycloalkyl-substituted aminomethylpyrrolidine derivatives |
| 06/03/2003 | CA2053954C Process for the preparation of nitroguanidine derivatives |
| 05/30/2003 | WO2003043960A2 IMPROVED PURIFICATION OF 4, 4'(5')-DI-t-BUTYLCYCLOHEXANO-18-CROWN-6 |
| 05/30/2003 | WO2003043633A1 Use of an ascomycin for the treatment of blepharitis |
| 05/30/2003 | WO2003043619A1 New use for the treatment of gastroesophageal reflux disease |
| 05/30/2003 | WO2003043618A2 Amino diols useful in the treatment of alzheimer's disease |
| 05/30/2003 | WO2003010141A3 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure |
| 05/30/2003 | CA2467549A1 Use of an ascomycin for the treatment of blepharitis |
| 05/30/2003 | CA2467476A1 Amino diols useful in the treatment of alzheimer's disease |
| 05/30/2003 | CA2466916A1 New use for the treatment of gastroesophageal reflux disease |
| 05/29/2003 | US20030100589 Modeled after unique toxins extracted from marine invertebrate Diazona angulata; useful in treatment of abnormal cell mitosis; antiproliferative agents and anticancer agents |
| 05/29/2003 | US20030100576 Methods and compounds for inhibiting mrp1 |
| 05/29/2003 | US20030100571 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease |
| 05/29/2003 | US20030100554 Pyrazole derivatives |
| 05/28/2003 | EP1314726A1 Novel ester or amide derivatives |
| 05/28/2003 | EP1313738A1 Process for the preparation and purification of thiol-containing maytansinoids |
| 05/28/2003 | EP1313718A2 Inhibitors of copper-containing amine oxidases |
| 05/28/2003 | EP1313481A1 Pharmaceutical composition comprising condensed indole compound |
| 05/28/2003 | EP1313476A2 Sgk2 and sgk3 used as diagnostic and therapeutic targets |
| 05/28/2003 | EP1155001A4 Isoquinoline derivatives and isoquinoline combinatorial libraries |